Xiaoyuan Zhang Selected Research

Therapeutics

11/2022	Effectiveness of fat grafting in scar reduction: A systematic review and meta-analysis.
4/2022	A bibliometric analysis of CD38-targeting antibody therapy in multiple myeloma from 1985 to 2021.
1/2022	Efficacy of Surgery in Patients with Stage I Primary Parotid Gland Lymphoma: A Population-Based Study.
1/2022	CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.
1/2022	A retrospective study of focused ultrasound versus cryotherapy in treatment of cervical squamous intraepithelial lesions.
1/2022	Effects of Tibetan medicine metacinnabar (β-HgS) combined with imipramine or sertraline on depression-like symptoms in mice.
12/2021	Stimulus-responsive nanomaterials under physical regulation for biomedical applications.
8/2021	Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications.
7/2021	Design of metal-organic framework composites in anti-cancer therapies.
1/2021	CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyuan Zhang Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 03/2014
7	Inflammation (Inflammations) 01/2023 - 03/2014
5	Myocardial Infarction 01/2022 - 12/2020
4	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 10/2020
4	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2021
4	Heart Failure 01/2022 - 12/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 10/2020
3	Overweight 01/2021 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2018
2	Cognitive Dysfunction 11/2023 - 01/2022
2	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 11/2023 - 01/2022
2	Wilms Tumor (Wilm's Tumor) 01/2023 - 01/2018
2	Pain (Aches) 01/2023 - 09/2015
2	Multiple Myeloma 04/2022 - 01/2022
2	Carcinogenesis 01/2022 - 01/2020
2	Atrophy 01/2022 - 08/2020
2	Cardiotoxicity 01/2022 - 03/2014
2	Lymphoma (Lymphomas) 01/2022 - 11/2016
2	Rupture 01/2021 - 01/2020
1	Cerebral Infarction 05/2024
1	Brain Hypoxia (Cerebral Hypoxia) 05/2024
1	Ischemia 05/2024
1	Hypoxia (Hypoxemia) 05/2024
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2024
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2024
1	Wounds and Injuries (Trauma) 11/2023
1	Asthenozoospermia 01/2023
1	Myoclonus (Nocturnal Myoclonus) 01/2023
1	Bradycardia 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Necrosis 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Tachycardia (Tachyarrhythmias) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022
1	Cicatrix (Scar) 11/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2016
5	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
4	Messenger RNA (mRNA)IBA 01/2024 - 01/2018
4	Intercellular Adhesion Molecule-3IBA 12/2022 - 08/2018
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2020
2	Sevoflurane (Ultane)FDA LinkGeneric 05/2024 - 11/2023
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 08/2020
2	Superoxide DismutaseIBA 01/2024 - 01/2022
2	AngiopoietinsIBA 01/2023 - 01/2022
2	Claudin-5IBA 01/2023 - 01/2018
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 04/2022
2	NPHS2 proteinIBA 01/2023 - 01/2018
2	podocalyxinIBA 01/2023 - 01/2018
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2022 - 01/2022
2	CalciumIBA 01/2022 - 01/2022
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 02/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 08/2020
2	Phosphorus (Red Phosphorus)IBA 01/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2021
2	Methylmalonic AcidIBA 01/2022 - 10/2020
2	CateninsIBA 01/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 10/2020
2	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2020
2	guanosine 5'-diphosphate-3'-monophosphateIBA 01/2021 - 01/2021
2	Histones (Histone)IBA 01/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 07/2015 - 03/2014
1	4- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA 05/2024
1	Neuroprotective AgentsIBA 05/2024
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2024
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 03/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024
1	Estrogen ReceptorsIBA 01/2024
1	CytokinesIBA 01/2024
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2024
1	ErbB Receptors (EGF Receptor)IBA 01/2024
1	CopperIBA 01/2024
1	Testosterone (Sustanon)FDA Link 01/2024
1	Phenobarbital (Luminal)FDA Link 01/2024
1	RGS ProteinsIBA 11/2023
1	General AnestheticsIBA 11/2023
1	MelatoninIBA 11/2023
1	Calcium Channels (Calcium Channel)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 10/2023
1	PolyHemeIBA 01/2023
1	Busulfan (Busulfex)FDA Link 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2023
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Etomidate FDA LinkGeneric 01/2023
1	ElastinIBA 01/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023
1	CollagenIBA 01/2023
1	AntibodiesIBA 04/2022

Therapy/Procedure

15	Therapeutics 11/2022 - 03/2014
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2021
2	Photothermal Therapy 08/2021 - 11/2019
1	Anesthesia 01/2023
1	Oral Administration 01/2023